Literature DB >> 33619585

Letter to the editor on "Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial".

Dongfeng Zhang1, Hao Wu1, Qingquan Kong2.   

Abstract

Entities:  

Year:  2021        PMID： 33619585     DOI： 10.1007/s00264-021-04988-5

Source DB:  PubMed          Journal:  Int Orthop        ISSN： 0341-2695            Impact factor:   3.075


× No keyword cloud information.
  4 in total

Review 1.  Efficacy and safety of tranexamic acid in reducing blood loss in scoliosis surgery: a systematic review and meta-analysis.

Authors:  Qiu-Ming Yuan; Zhi-Hu Zhao; Bao-Shan Xu
Journal:  Eur Spine J       Date:  2016-11-29       Impact factor: 3.134

2.  The effectiveness of low-dose and high-dose tranexamic acid in posterior lumbar interbody fusion: a double-blinded, placebo-controlled randomized study.

Authors:  Ki-Tack Kim; Cheung-Kue Kim; Yong-Chan Kim; Hyung-Suk Juh; Hyo-Jong Kim; Hyeon-Soo Kim; Se Jung Hong; Hwee Weng Dennis Hey
Journal:  Eur Spine J       Date:  2017-07-25       Impact factor: 3.134

3.  Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial.

Authors:  Lu Zhang; Yanming Li; Dong Liu; Xing Xiao; Tingjin Guan; Hongwei Yue; Haipeng Xue; Hongming Zhou; Guangjun Jiao; Wenliang Wu; Hongliang Wang; Haichun Liu; Chunyang Meng; Zhaozhong Sun; Yunzhen Chen
Journal:  Int Orthop       Date:  2020-07-17       Impact factor: 3.075

4.  Timing of Complications After Spinal Fusion Surgery.

Authors:  Daniel D Bohl; Matthew L Webb; Adam M Lukasiewicz; Andre M Samuel; Bryce A Basques; Junyoung Ahn; Kern Singh; Alexander R Vaccaro; Jonathan N Grauer
Journal:  Spine (Phila Pa 1976)       Date:  2015-10-01       Impact factor: 3.468
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.